SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO
SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced that it has been granted its sixth United States patent in the last year. All of these United States patents are related to the antipathogenic properties of silicon nitride.
Related news for (SINT)
- Breaking News: MoBot’s Latest Update as of 10/20/25 07:00 AM
- SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
- 24/7 Market News Snapshot 20 October, 2025 – SiNtx Technologies, Inc. Common Stock (NASDAQ:SINT)
- MoBot’s Stock Market Highlights – 09/05/25 01:00 PM
- Breaking News: MoBot’s Latest Update as of 09/05/25 12:00 PM
